SEC Form 4 · accession 0001104659-26-071048
Petros Pharmaceuticals, Inc. · PTPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fady Boctor
Officer — See Remarks
Period of report
Jun 5, 2026
Accepted (ET)
Jun 5, 2026 · 5:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001815903
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | A | 375,000 | $0.00 | A | 894,986 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date.
Remarks
President & Chief Commercial Officer